A randomized clinical study of specifically designed isoenergetic diets, together with fecal shotgun metagenomics, showed that a select group of short-chain fatty acid (SCFA)-producing strains of the gut microbiota was promoted by dietary fibers, and correlated with improved blood-glucose regulation in type 2 diabetes mellitus (T2D). The improvement in hemoglobin A1c levels was partly via increased glucagon-like peptide-1 production. Promotion of the positive responders diminished producers of metabolically detrimental compounds such as indole and hydrogen sulfide. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with T2D. The gut microbiota benefits humans via SCFA production from carbohydrate fermentation. Source: http://science.sciencemag.org/
In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…
A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…
People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
This website uses cookies.